Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Beckley Psytech
Recent news which mentions Beckley Psytech
Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth
November 13, 2024
Tickers
ATAI
DMT
MDMA
NEWS
Tags
Beckley Psytech
Market News
Cannabis
From
Benzinga
Beckley Psytech Doses First Patients With Psilocin In Trial For Treatment Of Major Depression Disorder
June 20, 2024
Tickers
NEWS
Tags
News
Rob Conley
premium
From
Benzinga
Imperial College Scientists Dose First Patient With 5-MeO-DMT To Examine One Of The Most Potent Psychedelics' Effects On The Brain
June 03, 2024
Tickers
NEWS
Tags
Beckley Psytech Ltd
Christopher Timmermann
Psychedelics
From
Benzinga
First Patient Dosed In Psychedelics Therapy Study For Treatment-Resistant Depression
April 26, 2024
Tickers
NEWS
Tags
treatment/resistant depression
Market News
Cannabis
From
Benzinga
UK-Based Approach To Alcohol Addiction: 5-MeO-DMT Candidate Moves To Phase 2 Clinical Stage
April 05, 2023
Tags
Psychedelic/Assisted Therapies
Beckley Psytech
Markets
From
Benzinga
Phase 2 Trial For This Psychedelic, Potential Treatment For Severe Depression
December 22, 2022
Tags
News
Treatment Resistant Depression
Psychedelics
From
Benzinga
Beyond Magic Mushrooms: Positive Clinical Trial For Treatment-Resistant Depression & Alcoholism
November 16, 2022
Tags
Psychedelics
Benzinga
News
From
Benzinga
Psychedelics M&A: Beckley Psytech Acquires Eleusis Therapeutics, Strengthening Drug Pipeline And R&D Team
October 24, 2022
Tags
Psychedelics
Benzinga
Dr/ Charles Nichols
From
Benzinga
Palo Santo Closes $50M Psychedelic Therapeutics Investment Fund
October 12, 2022
Tags
Cosmo Feilding Mellen
Daniel Goldberg
Multidisciplinary Association for Psychedelic Studies
From
Benzinga
Beckley Psytech Begins Training Therapists For Phase 2 Trial With Toad Venom, 5-MeO-DMT
January 24, 2022
Tags
Topics
General
Market News
From
Benzinga
Psyched: Beckley Psytech Raises $80M, Diamond Therapeutics To Study Psilocybin Microdosing, Mydecine and Johns Hopkins Partner Up
August 23, 2021
Tickers
CLABF
MYCOF
SILFF
Tags
Market News
Cannabis
CLABF
From
Benzinga
Beckley Psytech Reaches $100M Financing To Study 5-MeO-DMT, Psilocybin And Other Psychedelics
August 19, 2021
Tags
Market News
Cannabis
Beckley Psytech
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.